Please refer the attached intimation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Transchem Limited's Board approved audited FY2026 results (year ended March 31, 2026) with an unmodified (clean) audit opinion from Mathur & Co. Total income fell to ₹926.08 lakh from ₹1,116.29 lakh in FY2025, a decline of about 17%. Net profit dropped to ₹429.51 lakh from ₹522.59 lakh, down ~18% year-on-year. EPS stood at ₹3.51 versus ₹4.27 previously. Operating cash flow turned negative at -₹156.59 lakh compared to +₹3,600.03 lakh in the prior year, driven by a large increase in loans (financial assets). The company holds substantial cash reserves of ₹4,242.91 lakh. The Board also re-appointed M/s. L. T. Jadav & Co. as Internal Auditors for FY2026-27. A ₹75 crore warrant issuance (up to 6.15 crore warrants at ₹75 each) is awaiting BSE in-principle approval but no warrants have been allotted yet.
The stock may face pressure as revenue and profit both declined ~17-18% year-on-year and operating cash flow turned negative. However, the clean audit opinion and large cash reserves provide some stability.